These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28102531)

  • 21. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translation of in vitro to in vivo pyridinium oxime potential in tabun poisoning.
    Katalinić M; Maček Hrvat N; Žďárová Karasová J; Misik J; Kovarik Z
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):291-8. PubMed ID: 26751861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mini review on blood-brain barrier penetration of pyridinium aldoximes.
    Kalász H; Nurulain SM; Veress G; Antus S; Darvas F; Adeghate E; Adem A; Hashemi F; Tekes K
    J Appl Toxicol; 2015 Feb; 35(2):116-23. PubMed ID: 25291712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.
    Sit RK; Kovarik Z; Maček Hrvat N; Žunec S; Green C; Fokin VV; Sharpless KB; Radić Z; Taylor P
    J Pharmacol Exp Ther; 2018 Nov; 367(2):363-372. PubMed ID: 30190337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning.
    Worek F; Bäcker M; Thiermann H; Szinicz L; Mast U; Klimmek R; Eyer P
    Hum Exp Toxicol; 1997 Aug; 16(8):466-72. PubMed ID: 9292287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of sarin exposure.
    Krivoy A; Layish I; Rotman E; Yehezkelli Y
    JAMA; 2004 Jan; 291(2):181; author reply 182-3. PubMed ID: 14722138
    [No Abstract]   [Full Text] [Related]  

  • 28. Atropine use in children after nerve gas exposure.
    Lynch M
    J Pediatr Nurs; 2005 Dec; 20(6):477-84. PubMed ID: 16298290
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of sarin exposure.
    DeBalli P; Cook DR
    JAMA; 2004 Jan; 291(2):181-2; author reply 182-3. PubMed ID: 14722137
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of nerve agent exposure.
    Rotenberg JS
    Pediatr Ann; 2003 Apr; 32(4):242-50. PubMed ID: 12723119
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxime-type acetylcholinesterase reactivators in pregnancy: an overview.
    Nurulain SM; Kornelia T; Naqvi SN; Sharma C; Ojha S; Adem A
    Arch Toxicol; 2014 Mar; 88(3):575-84. PubMed ID: 24258240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment for nerve-poisoning agents.
    FDA Consum; 2006; 40(6):6. PubMed ID: 17333555
    [No Abstract]   [Full Text] [Related]  

  • 34. Amidine-oximes: reactivators for organophosphate exposure.
    Kalisiak J; Ralph EC; Zhang J; Cashman JR
    J Med Chem; 2011 May; 54(9):3319-30. PubMed ID: 21438612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of novel oximes for treatment of poisoning by organophosphorus compounds.
    Worek F; Thiermann H
    Pharmacol Ther; 2013 Aug; 139(2):249-59. PubMed ID: 23603539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical warfare--the nerve gases.
    Baraka A
    Middle East J Anaesthesiol; 1991 Feb; 11(1):5-23. PubMed ID: 2067504
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
    Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
    Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Tokyo subway sarin attack--lessons learned.
    Okumura T; Hisaoka T; Yamada A; Naito T; Isonuma H; Okumura S; Miura K; Sakurada M; Maekawa H; Ishimatsu S; Takasu N; Suzuki K
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):471-6. PubMed ID: 15979676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats.
    Myhrer T; Mariussen E; Enger S; Aas P
    Neurotoxicology; 2015 Sep; 50():142-8. PubMed ID: 26318504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug development for the management of organophosphorus poisoning.
    Elsinghorst PW; Worek F; Thiermann H; Wille T
    Expert Opin Drug Discov; 2013 Dec; 8(12):1467-77. PubMed ID: 24125474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.